Tumour necrosis factor and Crohn's diseaseVAN DEVENTER, S. J. H.Gut. 1997, Vol 40, Num 4, pp 443-448, issn 0017-5749Article

Immunomodulation of Crohn's disease using TNF-α neutralizing monoclonal antibodiesVAN DEVENTER, S. J. H.Clinical nutrition (Edinburgh). 1997, Vol 16, Num 6, pp 271-275, issn 0261-5614Article

Anti-tumour necrosis factor therapy in Crohn's disease: Where are we now?VAN DEVENTER, S. J. H.Gut. 2002, Vol 51, Num 3, pp 362-363, issn 0017-5749Article

Cytokines and mucosal inflammatory response in Crohn's diseaseVAN DEVENTER, S. J. H.The European journal of surgery. 1998, Vol 164, Num 12, pp 897-901, issn 1102-4151Conference Paper

Infliximab therapy in Crohn's disease: safety issuesHOMMES, D. W; VAN DEVENTER, S. J. H.Netherlands journal of medicine. 2003, Vol 61, Num 4, pp 100-104, issn 0300-2977, 5 p.Article

Small therapeutic molecules for the treatment of inflammatory bowel diseaseVAN DEVENTER, S. J. H.Gut. 2002, Vol 50, pp iii47-iii53, issn 0017-5749, SUP3Conference Paper

Taming the mucosal immune response in Crohn's diseaseVAN DEVENTER, S. J. H.Baillière's best practice & research. Clinical gastroenterology. 2002, Vol 16, Num 6, pp 1035-1043, issn 1521-6918, 9 p.Article

Interleukin 1β is expressed predominantly by enterocytes in experimental colitisRADEMA, S. A; VAN DEVENTER, S. J. H; CERAMI, A et al.Gastroenterology (New York, NY. 1943). 1991, Vol 100, Num 5, pp 1180-1186, issn 0016-5085, 7 p.Article

PouchitisTYTGAT, G. N. J; VAN DEVENTER, S. J. H.International journal of colorectal disease (Print). 1988, Vol 3, Num 4, pp 226-228, issn 0179-1958Article

Elevated levels of homocysteine increase IL-6 production in monocytic Mono Mac 6 cellsVAN AKEN, B. E; JANSEN, J; VAN DEVENTER, S. J. H et al.Blood coagulation & fibrinolysis. 2000, Vol 11, Num 2, pp 159-164, issn 0957-5235Article

Intestinal endotoxemia: clinical significanceVAN DEVENTER, S. J. H; TEN CATE, J. W; TYTGAT, G. N. J et al.Gastroenterology (New York, NY. 1943). 1988, Vol 94, Num 3, pp 825-831, issn 0016-5085, 7 p.Article

Multiple doses of intravenous Interleukin 10 in steroid-refractory Crohn's diseaseVAN DEVENTER, S. J. H; ELSON, C. O; FEDORAK, R. N et al.Gastroenterology (New York, NY. 1943). 1997, Vol 113, Num 2, pp 383-389, issn 0016-5085Article

The cellular response in sepsisPAJKRT, D; VAN DEVENTER, S. J. H.Current Topics in Microbiology and Immunology. 1996, Vol 216, pp 119-132, issn 0070-217XArticle

Pathogenesis of disseminated intravascular coagulation in sepsisLEVI, M; TEN CATE, H; VAN DER POLL, T et al.JAMA, the journal of the American Medical Association. 1993, Vol 270, Num 8, pp 975-979, issn 0098-7484Article

Treatment with recombinant bactericidal/permeability-increasing protein to prevent endotoxin-induced mortality in bile duct-ligated ratsKIMMINGS, A. N; VAN DEVENTER, S. J. H; OBERTOP, H et al.Journal of the American College of Surgeons. 1999, Vol 189, Num 4, pp 374-379, issn 1072-7515Article

Anti-TNF antibody treatment of Crohn's diseaseVAN DEVENTER, S. J. H.Annals of the rheumatic diseases. 1999, Vol 58, pp I114-I120, issn 0003-4967, SUP1Article

The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemiaLEVI, M; VAN DER POLL, T; TEN CATE, H et al.European journal of clinical investigation. 1997, Vol 27, Num 1, pp 3-9, issn 0014-2972Article

Model for whole body production of tumor necrosis factor-α in experimental endotoxaemia in healthy subjectsKOOPMANS, R; HOEK, F. J; VAN DEVENTER, S. J. H et al.Clinical science (1979). 1994, Vol 87, Num 4, pp 459-465, issn 0143-5221Article

Immunopathogenesis of IBD : Insufficient suppressor function in the gut?HUIBREGTSE, I. L; VAN LENT, A. U; VAN DEVENTER, S. J. H et al.Gut. 2007, Vol 56, Num 4, pp 584-592, issn 0017-5749, 9 p.Article

Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targetsHOMMES, D. W; PEPPELENBOSCH, M. P; VAN DEVENTER, S. J. H et al.Gut. 2003, Vol 52, Num 1, pp 144-151, issn 0017-5749, 8 p.Article

Current drug treatment strategies for disseminated intravascular coagulationDE JONGE, E; LEVI, M; STOUTENBEEK, C. P et al.Drugs (Basel). 1998, Vol 55, Num 6, pp 767-777, issn 0012-6667Article

Tumor necrosis factor (TNF) in inflammatory bowel disease : Gene polymorphisms, animal models, and potential for anti-TNF therapySTOKKERS, P. C. F; CAMOGLIO, L; VAN DEVENTER, S. J. H et al.Journal of inflammation. 1995, Vol 47, Num 1-2, pp 97-103, issn 1078-7852Conference Paper

Intravenous infusion of erythromycin inhibits CXC chemokine production, but augments neutrophil degranulation in whole blood stimulated with Streptococcus pneumoniaeSCHULTZ, M. J; SPEELMAN, P; HACK, C. E et al.Journal of antimicrobial chemotherapy (Print). 2000, Vol 46, Num 2, pp 235-240, issn 0305-7453Article

Erythromycin inhibits tumor necrosis factor alpha and interleukin 6 production induced by heat-killed Streptococcus pneumoniae in whole bloodSCHULTZ, M. J; SPEELMAN, P; ZAAT, S et al.Antimicrobial agents and chemotherapy. 1998, Vol 42, Num 7, pp 1605-1609, issn 0066-4804Article

Treatment of therapy-resistant perineal metastatic Crohn's disease after proctectomy using anti-tumor necrosis factor chimeric monoclonal antibody, cA2 : Report of two casesVAN DULLEMEN, H. M; DE JONG, E; SLORS, F et al.Diseases of the colon & rectum. 1998, Vol 41, Num 1, pp 98-102, issn 0012-3706Article